Apparently this year’s nobel prize in medicine goes to James P. Allison and Tasuku Honjo for their work on finding a way to ”unleash” the body’s immune system to attack cancer.
It has resulted in a bunch of medicines: ipilimumab (Yervoy), nivolumab (Opdivo), pembrolizumab (Keytruda), etc.
Wonder if we’ll see these used together with TKIs in the future?